Norges Bank Acquires New Stake in Revvity Inc. $RVTY

Norges Bank bought a new stake in Revvity Inc. (NYSE:RVTY) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 830,824 shares of the company’s stock, valued at approximately $80,382,000. Norges Bank owned approximately 0.73% of Revvity as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of RVTY. CYBER HORNET ETFs LLC acquired a new stake in shares of Revvity in the 2nd quarter worth $32,000. Cromwell Holdings LLC increased its stake in shares of Revvity by 141.4% in the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after acquiring an additional 198 shares during the last quarter. MUFG Securities EMEA plc acquired a new stake in shares of Revvity in the 2nd quarter worth $34,000. Headlands Technologies LLC acquired a new stake in shares of Revvity in the 2nd quarter worth $49,000. Finally, Smartleaf Asset Management LLC increased its stake in shares of Revvity by 56.8% in the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after acquiring an additional 250 shares during the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have issued reports on RVTY shares. Stifel Nicolaus cut their target price on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. The Goldman Sachs Group cut their target price on Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a research note on Tuesday, April 14th. Wolfe Research started coverage on Revvity in a research note on Tuesday, June 2nd. They issued a “peer perform” rating for the company. TD Cowen raised their target price on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, Barclays increased their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $107.73.

Revvity Stock Performance

NYSE RVTY opened at $98.46 on Friday. The stock has a market cap of $10.98 billion, a PE ratio of 47.11, a P/E/G ratio of 2.15 and a beta of 1.11. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $118.30. The stock has a fifty day simple moving average of $93.40 and a 200-day simple moving average of $97.49.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The business had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. During the same period in the prior year, the business posted $1.01 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities analysts anticipate that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is 13.40%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.